Li M, Mo T, Yang Z, Yao Y, Wang Y, Zhao Y
Curr Treat Options Oncol. 2025; 26(1):45-54.
PMID: 39810047
DOI: 10.1007/s11864-024-01284-3.
Youssef A, Sahgal A, Das S
Front Oncol. 2024; 14:1477448.
PMID: 39540151
PMC: 11557554.
DOI: 10.3389/fonc.2024.1477448.
Lin N, Hsia S, Vu Nguyen T, Wang T, Sun K, Chiu K
J Dent Sci. 2024; 19(4):2074-2081.
PMID: 39347098
PMC: 11437243.
DOI: 10.1016/j.jds.2024.05.001.
Jalali-Zefrei F, Mousavi S, Delpasand K, Shourmij M, Farzipour S
Curr Gene Ther. 2024; 25(2):113-135.
PMID: 38676526
DOI: 10.2174/0115665232301727240422092311.
Hou W, Xu L, Su T, Wu Y, Liu Y, Wei Y
Appl Biochem Biotechnol. 2023; 196(1):275-295.
PMID: 37119503
DOI: 10.1007/s12010-023-04558-y.
The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer.
Roh J, Im M, Chae Y, Kang J, Kim W
Int J Mol Sci. 2022; 23(23).
PMID: 36499136
PMC: 9738059.
DOI: 10.3390/ijms232314808.
LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysis.
Xie Y, Han J, Xie K, Gou Q
Sci Rep. 2022; 12(1):18494.
PMID: 36323697
PMC: 9630540.
DOI: 10.1038/s41598-022-21785-1.
Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology.
Kozlowska-Maslon J, Guglas K, Paszkowska A, Kolenda T, Podralska M, Teresiak A
J Pers Med. 2022; 12(10).
PMID: 36294743
PMC: 9604926.
DOI: 10.3390/jpm12101605.
Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding.
Pasieka R, Zasonski G, Raczynska K
Mol Diagn Ther. 2022; 27(1):29-47.
PMID: 36287372
PMC: 9813052.
DOI: 10.1007/s40291-022-00619-w.
Epigenetic factors in breast cancer therapy.
Mathur R, Jha N, Saini G, Jha S, Shukla S, Filipejova Z
Front Genet. 2022; 13:886487.
PMID: 36212140
PMC: 9539821.
DOI: 10.3389/fgene.2022.886487.
The Long and the Short of It: and Cancer Cell Metabolism.
Smith N, Spencer-Merris P, Fox A, Petersen J, Michael M
Cancers (Basel). 2022; 14(18).
PMID: 36139550
PMC: 9497099.
DOI: 10.3390/cancers14184388.
Long Noncoding RNA lncR17454 Regulates Metamorphosis of Silkworm Through let-7 miRNA Cluster.
Fu Y, Wang Y, Huang Q, Zhao C, Li X, Kan Y
J Insect Sci. 2022; 22(3).
PMID: 35640247
PMC: 9155153.
DOI: 10.1093/jisesa/ieac028.
Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
Qiu C, Li C, Zheng Q, Fang S, Xu J, Wang H
Bioengineered. 2022; 13(5):11987-12002.
PMID: 35603556
PMC: 9275981.
DOI: 10.1080/21655979.2021.2005981.
Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities.
Wang H, Wang W, Fan S
Int J Biol Sci. 2022; 18(7):2714-2728.
PMID: 35541920
PMC: 9066117.
DOI: 10.7150/ijbs.70292.
Recent advances of NEAT1-miRNA interactions in cancer.
Zhou H, Wang Y, Liu Z, Zhang Z, Xiong L, Wen Y
Acta Biochim Biophys Sin (Shanghai). 2022; 54(2):153-162.
PMID: 35538025
PMC: 9827865.
DOI: 10.3724/abbs.2021022.
Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies.
Qiao L, Chen Y, Liang N, Xie J, Deng G, Chen F
Front Oncol. 2022; 12:775238.
PMID: 35251963
PMC: 8888452.
DOI: 10.3389/fonc.2022.775238.
Exploring clinical implications and role of non-coding RNAs in lung carcinogenesis.
Roy S, Ganguly N, Banerjee S
Mol Biol Rep. 2022; 49(7):6871-6883.
PMID: 35076850
DOI: 10.1007/s11033-022-07159-w.
Confers Radioresistance to Hepatocellular Carcinoma Cells by Inducing Autophagy through GABARAP.
Sakaguchi H, Tsuchiya H, Kitagawa Y, Tanino T, Yoshida K, Uchida N
Int J Mol Sci. 2022; 23(2).
PMID: 35054896
PMC: 8775719.
DOI: 10.3390/ijms23020711.
Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma.
Xiao J, He X
Cancer Manag Res. 2021; 13:8781-8794.
PMID: 34849030
PMC: 8627240.
DOI: 10.2147/CMAR.S336265.
NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.
Li K, Yao T, Zhang Y, Li W, Wang Z
Int J Biol Sci. 2021; 17(13):3428-3440.
PMID: 34512157
PMC: 8416723.
DOI: 10.7150/ijbs.62728.